List of Conzip drug patents

Conzip is owned by Cipher Pharms Inc.

Conzip contains Tramadol Hydrochloride.

Conzip has a total of 1 drug patent out of which 1 drug patent has expired.

Expired drug patents of Conzip are:

  • US7858118

Conzip was authorised for market use on 07 May, 2010.

Conzip is available in capsule, extended release;oral dosage forms.

Conzip can be used as use of tramadol for the management of moderate to moderately severe chronic pain.

The generics of Conzip are possible to be released after 11 April, 2022.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7858118 CIPHER PHARMS INC Extended release composition containing Tramadol
Apr, 2022

(1 year, 1 month ago)

Do you want to check out CONZIP patents from before 2022?

Drugs and Companies using TRAMADOL HYDROCHLORIDE ingredient

Market Authorisation Date: 07 May, 2010

Treatment: Use of tramadol for the management of moderate to moderately severe chronic pain

Dosage: CAPSULE, EXTENDED RELEASE;ORAL

More Information on Dosage

CONZIP family patents

6

United States

1

Canada

1

Australia

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in